Question 1

Drug resistant tuberculosis (TB) is defined as TB that is resistant to:

Accepted Answer

A)  Fluoroquinolones 
B)  Rifampin and isoniazid 
C)  Amoxicillin 
D)  Ceftriaxone 
A)  Fluoroquinolones 
B)  Rifampin and isoniazid 
C)  Amoxicillin 
D)  Ceftriaxone B

Question 2

Leonard is completing a 6-month regimen to treat tuberculosis (TB). Monitoring of a patient on TB therapy includes:

Accepted Answer

A)  Monthly sputum cultures 
B)  Monthly chest x-ray 
C)  Bronchoscopy every 3 months 
D)  All of the above 
A)  Monthly sputum cultures 
B)  Monthly chest x-ray 
C)  Bronchoscopy every 3 months 
D)  All of the above A

Question 3

Isabella has confirmed tuberculosis and is placed on a 6-month treatment regimen. The 6-month regimen consists of:

Accepted Answer

A)  Two months of four-drug therapy (INH, rifampin, pyrazinamide, and ethambutol) followed by Four months of INH and rifampin 
B)  Six months of INH with daily pyridoxine throughout therapy 
C)  Six months of INH, rifampin, pyrazinamide, and ethambutol 
D)  Any of the above 
A)  Two months of four-drug therapy (INH, rifampin, pyrazinamide, and ethambutol) followed by Four months of INH and rifampin 
B)  Six months of INH with daily pyridoxine throughout therapy 
C)  Six months of INH, rifampin, pyrazinamide, and ethambutol 
D)  Any of the above A

Question 4

The principles of drug therapy for the treatment of tuberculosis include:

Accepted Answer

A)  Patients are treated with a drug to which M. tuberculosis is sensitive. 
B)  Drugs need to be taken on a regular basis for a sufficient amount of time. 
C)  Treatment continues until the patient's purified protein derivative is negative. 
D)  All of the above 
A)  Patients are treated with a drug to which M. tuberculosis is sensitive. 
B)  Drugs need to be taken on a regular basis for a sufficient amount of time. 
C)  Treatment continues until the patient's purified protein derivative is negative. 
D)  All of the above

Question 5

Goals when treating tuberculosis include:

Accepted Answer

A)  Completion of recommended therapy 
B)  Negative purified protein derivative at the end of therapy 
C)  Completely normal chest x-ray 
D)  All of the above 
A)  Completion of recommended therapy 
B)  Negative purified protein derivative at the end of therapy 
C)  Completely normal chest x-ray 
D)  All of the above

Question 6

Bilal is a 5-year-old patient who has been diagnosed with tuberculosis. His treatment would include:

Accepted Answer

A)  Pyridoxine 
B)  Ethambutol 
C)  Levofloxacin 
D)  Rifabutin 
A)  Pyridoxine 
B)  Ethambutol 
C)  Levofloxacin 
D)  Rifabutin

Question 7

Compliance with directly observed therapy can be increased by:

Accepted Answer

A)  Convenient clinic times 
B)  Incentives such as food, clothing, and transportation costs 
C)  Offering gifts for compliance 
D)  All of the above 
A)  Convenient clinic times 
B)  Incentives such as food, clothing, and transportation costs 
C)  Offering gifts for compliance 
D)  All of the above

Question 8

Kaleb has extensively resistant tuberculosis (TB). Treatment for extensively resistant TB would include:

Accepted Answer

A)  INH, rifampin, pyrazinamide, and ethambutol for at least 12 months 
B)  INH, ethambutol, kanamycin, and rifampin 
C)  Treatment with at least two drugs to which the TB is susceptible 
D)  Levofloxacin 
A)  INH, rifampin, pyrazinamide, and ethambutol for at least 12 months 
B)  INH, ethambutol, kanamycin, and rifampin 
C)  Treatment with at least two drugs to which the TB is susceptible 
D)  Levofloxacin

Question 9

Ezekiel is a 9-year-old patient who lives in a household with a family member newly diagnosed with tuberculosis (TB). To prevent Ezekiel from developing TB he should be treated with:

Accepted Answer

A)  6 months of Isoniazid (INH) and rifampin 
B)  2 months of INH, rifampin, pyrazinamide, and ethambutol, followed by 4 months of INH 
C)  9 months of INH 
D)  12 months of INH 
A)  6 months of Isoniazid (INH) and rifampin 
B)  2 months of INH, rifampin, pyrazinamide, and ethambutol, followed by 4 months of INH 
C)  9 months of INH 
D)  12 months of INH

Question 10

Lila is 24 weeks pregnant and has been diagnosed with tuberculosis (TB). Treatment regimens for a pregnant patient with TB would include:

Accepted Answer

A)  Streptomycin 
B)  Levofloxacin 
C)  Kanamycin 
D)  Pyridoxine 
A)  Streptomycin 
B)  Levofloxacin 
C)  Kanamycin 
D)  Pyridoxine

Exam 45: Tuberculosis

Drug resistant tuberculosis (TB) is defined as TB that is resistant to:

Leonard is completing a 6-month regimen to treat tuberculosis (TB). Monitoring of a patient on TB therapy includes:

Isabella has confirmed tuberculosis and is placed on a 6-month treatment regimen. The 6-month regimen consists of:

The principles of drug therapy for the treatment of tuberculosis include:

Goals when treating tuberculosis include:

Bilal is a 5-year-old patient who has been diagnosed with tuberculosis. His treatment would include:

Compliance with directly observed therapy can be increased by:

Kaleb has extensively resistant tuberculosis (TB). Treatment for extensively resistant TB would include:

Ezekiel is a 9-year-old patient who lives in a household with a family member newly diagnosed with tuberculosis (TB). To prevent Ezekiel from developing TB he should be treated with:

Lila is 24 weeks pregnant and has been diagnosed with tuberculosis (TB). Treatment regimens for a pregnant patient with TB would include:

The Role of the Nurse Practitioner

Review of Basic Principles of Pharmacology

Rational Drug Selection

Legal and Professional Issues in Prescribing

Adverse Drug Reactions

Factors That Foster Positive Outcomes

Cultural and Ethnic Influences in Pharmacotherapeutics

An Introduction to Pharmacogenomics

Nutrition and Nutraceuticals

Herbal Therapy and Nutritional Supplements

Information Technology and Pharmacotherapeutics

Pharmacoeconomics

Over-The-Counter Medications

Drugs Affecting the Autonomic Nervous System

Drugs Affecting the Central Nervous System

Drugs Affecting the Cardiovascular and Renal Systems

Drugs Affecting the Respiratory System

Drugs Affecting the Hematopoietic System

Drugs Affecting the Immune System

Drugs Affecting the Gastrointestinal System

Drugs Affecting the Endocrine System

Drugs Affecting the Reproductive System

Drugs Affecting the Integumentary System

Drugs Used in Treating Infectious Diseases

Drugs Used in Treating Inflammatory Processes

Drugs Used in Treating Eye and Ear Disorders

Anemia

Chronic Stable Angina and Low-Risk Unstable Angina

Anxiety and Depression

Asthma and Chronic Obstructive Pulmonary Disease

Contraception

Dermatologic Conditions

Diabetes Mellitus

Gastroesophageal Reflux and Peptic Ulcer Disease

Headaches

Heart Failure

Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome

Hormone Replacement Therapy and Osteoporosis

Hyperlipidemia

Hypertension

Hyperthyroidism and Hypothyroidism

Pneumonia

Smoking Cessation

Sexually Transmitted Infections and Vaginitis

Upper Respiratory Infections, Otitis Media, and Otitis Externa

Urinary Tract Infections

Women As Patients

Men As Patients

Children As Patients

Geriatric Patients

Pain Management: Acute and Chronic Pain

Filters